Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 8Breast 6Genitourinary 4Tumor-Agnostic 3Other 3Thoracic 2Lymphoid 2Sarcoma 1Other hematologic neoplasm 1Head & Neck 1Endocrine 1

Conditions

Neoplasms 3

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Electroacupuncture × Tumor-Agnostic × Clear all
NCT06340906 2026-02-13

Electroacupuncture in Symptom Management After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

University of California, Irvine

Phase NA Active not recruiting
20 enrolled
Tumor-Agnostic

Neoplasms

NCT05283577 2026-01-23

EAST

University of California, Irvine

Phase NA Active not recruiting
70 enrolled
Tumor-Agnostic

Neoplasms

NCT06891521 2025-03-24

Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy

Qinghai Red Cross Hospital

Phase 2 Not yet recruiting
123 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡